UA92013C2 - Novel indoline compounds - Google Patents

Novel indoline compounds

Info

Publication number
UA92013C2
UA92013C2 UAA200713357A UAA200713357A UA92013C2 UA 92013 C2 UA92013 C2 UA 92013C2 UA A200713357 A UAA200713357 A UA A200713357A UA A200713357 A UAA200713357 A UA A200713357A UA 92013 C2 UA92013 C2 UA 92013C2
Authority
UA
Ukraine
Prior art keywords
indoline compounds
novel indoline
novel
compounds
sulphonylindoline
Prior art date
Application number
UAA200713357A
Other languages
English (en)
Ukrainian (uk)
Inventor
Люк Лебретон
Кристин Дюма
Кристин Массардье
Мишель Бонду
Original Assignee
Лаборатуар Фурнье С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лаборатуар Фурнье С.А. filed Critical Лаборатуар Фурнье С.А.
Publication of UA92013C2 publication Critical patent/UA92013C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Изобретение касается соединений сульфонилиндолина формулы И, как определено в формуле изобретения, способа их получения и их применения в терапии, в частности для предупреждения или лечения нейродегенерации, сердечно-сосудистого заболевания, воспалительного заболевания, гиперхолестеринемии, дислипидемии, ожирения и диабета.
UAA200713357A 2005-05-30 2006-05-29 Novel indoline compounds UA92013C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0505432A FR2886293B1 (fr) 2005-05-30 2005-05-30 Nouveaux composes de l'indoline

Publications (1)

Publication Number Publication Date
UA92013C2 true UA92013C2 (en) 2010-09-27

Family

ID=35501068

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200713357A UA92013C2 (en) 2005-05-30 2006-05-29 Novel indoline compounds

Country Status (28)

Country Link
US (1) US7465811B2 (ru)
EP (1) EP1885695B8 (ru)
JP (1) JP2008545736A (ru)
KR (1) KR20080021609A (ru)
CN (2) CN102746214A (ru)
AT (1) ATE423768T1 (ru)
AU (1) AU2006263745B2 (ru)
BR (1) BRPI0610064A2 (ru)
CA (1) CA2611128A1 (ru)
CY (1) CY1109043T1 (ru)
DE (1) DE602006005356D1 (ru)
DK (1) DK1885695T3 (ru)
EA (1) EA012971B1 (ru)
ES (1) ES2322620T3 (ru)
FR (1) FR2886293B1 (ru)
HR (1) HRP20090243T1 (ru)
IL (1) IL187413A (ru)
MA (1) MA29494B1 (ru)
MX (1) MX2007015070A (ru)
NO (1) NO20075841L (ru)
PL (1) PL1885695T3 (ru)
PT (1) PT1885695E (ru)
RS (1) RS50969B (ru)
SI (1) SI1885695T1 (ru)
TN (1) TNSN07448A1 (ru)
UA (1) UA92013C2 (ru)
WO (1) WO2007000550A2 (ru)
ZA (1) ZA200710258B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2869904B1 (fr) * 2004-05-07 2006-07-28 Fournier S A Sa Lab Modulateurs des recepteurs lxr
GB0526257D0 (en) 2005-12-22 2006-02-01 Novartis Ag Organic compounds
AR071375A1 (es) * 2008-04-22 2010-06-16 Solvay Pharm Gmbh Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto
TWI748194B (zh) * 2018-06-28 2021-12-01 德商菲尼克斯 Ｆｘｒ有限責任公司 含有雙環核心部分之新穎lxr調節劑
CN114773190A (zh) * 2022-04-20 2022-07-22 江西天宇化工有限公司 一种制备2,4-二氯苯氧乙酸异辛酯的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316503B1 (en) * 1999-03-15 2001-11-13 Tularik Inc. LXR modulators
US6855708B2 (en) * 2001-03-20 2005-02-15 Merck & Co., Inc. N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors
TW200303742A (en) * 2001-11-21 2003-09-16 Novartis Ag Organic compounds
DE10229777A1 (de) * 2002-07-03 2004-01-29 Bayer Ag Indolin-Phenylsulfonamid-Derivate
FR2869904B1 (fr) * 2004-05-07 2006-07-28 Fournier S A Sa Lab Modulateurs des recepteurs lxr

Also Published As

Publication number Publication date
HK1112235A1 (zh) 2008-08-29
AU2006263745A1 (en) 2007-01-04
IL187413A0 (en) 2008-02-09
CY1109043T1 (el) 2014-07-02
FR2886293B1 (fr) 2007-08-24
ES2322620T3 (es) 2009-06-23
EA012971B1 (ru) 2010-02-26
EP1885695B8 (fr) 2009-08-12
RS50969B (sr) 2010-10-31
EP1885695A2 (fr) 2008-02-13
ATE423768T1 (de) 2009-03-15
PL1885695T3 (pl) 2009-10-30
CA2611128A1 (fr) 2007-01-04
IL187413A (en) 2011-10-31
EA200702324A1 (ru) 2008-04-28
TNSN07448A1 (fr) 2009-03-17
DE602006005356D1 (de) 2009-04-09
US7465811B2 (en) 2008-12-16
CN102746214A (zh) 2012-10-24
WO2007000550A2 (fr) 2007-01-04
CN101184731A (zh) 2008-05-21
DK1885695T3 (da) 2009-05-18
KR20080021609A (ko) 2008-03-07
EP1885695B1 (fr) 2009-02-25
HRP20090243T1 (hr) 2009-06-30
MA29494B1 (fr) 2008-05-02
NO20075841L (no) 2008-01-21
SI1885695T1 (sl) 2009-08-31
BRPI0610064A2 (pt) 2011-10-18
US20080119465A1 (en) 2008-05-22
WO2007000550A3 (fr) 2007-02-22
MX2007015070A (es) 2008-01-24
JP2008545736A (ja) 2008-12-18
FR2886293A1 (fr) 2006-12-01
ZA200710258B (en) 2009-10-28
AU2006263745B2 (en) 2012-03-15
PT1885695E (pt) 2009-05-20

Similar Documents

Publication Publication Date Title
HUS2100051I1 (hu) Kompozíciók és eljárások sejtproliferációs rendellenességek kezelésére
NO2017019I1 (no) Diarylhydantoinforbindelse, farmasøytisk sammensetning og anvendelse derav
UA100007C2 (ru) Гетероциклические ингибиторы мек, их применение и фармацевтическая композиция, которая их содержит
TW200726753A (en) 2,4-diamino-pyrimidines as aurora inhibitors
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
GEP20125565B (en) Lactam compounds and their pharmaceutical use
EA201070422A1 (ru) Производные оксадиазола
NO20082594L (no) Pyrimidinylbenzotiofenforbindelser
EA201100007A1 (ru) Производные хиноксалиндиона
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
EA201170521A1 (ru) Новые соединения
MY142988A (en) Novel aminobenzophenone compounds
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TW200745004A (en) Novel compounds, their preparation and use
MX2007011023A (es) 2-(4-oxo-4h-quinazolin-3-il) acetamidas y su uso como antagonistas de vasopresin v3.
MX2009007337A (es) Indazoles sustituidos con 5-piridinona.
MX2008013196A (es) 5-amido-2-carboxiamida-indoles.
UA83875C2 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
MA32505B1 (fr) 5-alcynyl-pyrimidines
MY149606A (en) Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
TW200738659A (en) Novel compounds
UA90698C2 (en) Triazole substituted aminobenzophenone compounds
TW200700064A (en) Novel compounds
GEP20135733B (en) Novel diazeniumdiolate derivatives, their preparation method and pharmaceutical compositions containing them